08/14/2025
7:01 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/11/2025
12:04 PM | Chemomab Therapeutics (Subject)
Otto Erik (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025
10:45 AM | Chemomab Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SCHEDULE 13G | |
07/25/2025
3:33 PM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2025
3:05 PM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/23/2025
4:06 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SCHEDULE 13D/A | |
05/15/2025
7:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/15/2025
7:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
4:25 PM | Chemomab Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SCHEDULE 13G/A | |
04/04/2025
4:17 PM | Chemomab Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
03/27/2025
7:30 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for CMMB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/20/2025
4:14 PM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025
7:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/19/2025
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
12/02/2024
3:22 PM | Chemomab Therapeutics (Filer)
| Form POS AM | |
11/29/2024
2:04 PM | Chemomab Therapeutics (Subject)
Mor George Adi (Filed by)
| Form SC 13D/A | |
11/21/2024
9:59 AM | Chemomab Therapeutics (Subject)
Otto Erik (Filed by)
| Form SC 13G | |
11/18/2024
3:19 PM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
3:34 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
| Form SC 13D/A | |
09/12/2024
3:56 PM | Chemomab Therapeutics (Subject)
OrbiMed Israel GP Ltd. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:16 AM | Chemomab Therapeutics (Filer)
| Form 424B3 | |
09/08/2024
11:15 PM | Chemomab Therapeutics (Filer)
| Form EFFECT | |
08/21/2024
6:00 AM | Chemomab Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024
1:36 PM | Chemomab Therapeutics (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
MarketBeat All Access